Nevro Corp.
1800 Bridge Parkway
Redwood City, CA 94065
January 8, 2024
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Robert Augustin
| Re: | Nevro Corp. |
Registration Statement on Form S-3
Filed December 29, 2023
Registration No. 333-276306
Dear Mr. Augustin:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Nevro Corp. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated by the Securities and Exchange Commission to 4:30 p.m. Washington D.C. time on January 10, 2024, or as soon as practicable thereafter, or at such later time as the Company or its counsel may request via telephone call to the staff. Please contact Daniel Rees of Latham & Watkins LLP, counsel to the Company, at (714) 755-2244, or in his absence, Phillip S. Stoup of Latham & Watkins LLP at (415) 395-8216, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Thank you for your assistance in this matter.
* * * *
| Sincerely, | ||
| Nevro Corp. | ||
| By: | /s/ Kevin Thornal | |
| Kevin Thornal | ||
| Chief Executive Officer and President | ||
| CC: | Kashif Rashid, Senior Vice President and General Counsel |
Daniel Rees, Latham & Watkins LLP
Phillip S. Stoup, Latham & Watkins LLP
